SCHEMBL12698702

SCHEMBL12698702

Nc1ccc(C(=O)N2CCN(C(=O)c3cc(F)cc(F)c3)CC2)cc1OC(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPK7 Q13164 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ HRH3 Q9Y5N1 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ DPP4 P27487 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ CREBBP Q92793 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4246868 0.86 EPHX2 (0.54) ALDH1A1MAPK7HRH3MEN1KMT2A
SCHEMBL17076840 0.84 EPHX2 (0.54) KMT2AEPHX2L3MBTL1
SCHEMBL20750406 0.84 PKM (0.50) HSD11B1MAPK7
SCHEMBL21230134 0.80 HSD11B1 (0.44) HSD11B1SMN1; SMN2ALDH1A1CA12CA1
SCHEMBL20192298 0.79 KDM4E (0.46) ALDH1A1
SCHEMBL20192521 0.76 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1LMNACYP3A4DPP4
SCHEMBL12698680 0.75 LSS (0.46) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL2477262 0.75 RORC (0.53) MEN1KMT2A
SCHEMBL20750455 0.74 NAMPT (0.49) HSD11B1MAPK7HRH3CREBBPEPHX2
SCHEMBL15880929 0.74 ALDH1A1 (0.59) HSD11B1SMN1; SMN2ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 — — WO disclosed
WO-2012092442-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2012-07-05 — — WO disclosed
Send feedback